Acute erythroid and megakaryocytic leukemia, BCL-xL dependence: it’s not time to retire morphology or your microscopes just yet.
I read with much interest the manuscript by Dr. Kuusanmäki et al. In the latest issue of Blood. (Click the hyperlink to see the paper)
They show convincing evidence that myeloid neoplasms with erythroid or megakaryocytic differentiation including acute erythroid leukemia (WHO 5th ed; =>80% eryhtroids, =>30% of which are immature/pronormoblasts, AKA pure…
Keep reading with a 7-day free trial
Subscribe to Sanam’s Substack to keep reading this post and get 7 days of free access to the full post archives.